CHELMSFORD, Mass., October 31, 2022--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated ...

TherOx Inc., an Irvine-based medical device maker in business for more than 20 years and with more than $150 million invested in it over its history, has been acquired, two months after the company ...

Important Milestone Toward Bringing SSO 2 Therapy to the U.S. Market Simon Dixon, MBChB, chair of cardiovascular medicine at Beaumont Hospital Royal Oak and an investigator for this study, noted, “In ...

SAN DIEGO - A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) ...

ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the Centers for Medicare & Medicaid Services (CMS) ICD-10 Coordination ...

One small med-tech firm is developing a system that is intended to provide interventional cardiologists with the first treatment option beyond percutaneous coronary intervention (PCI) to salvage heart ...

size after an AMI. This study is being conducted to support a PreMarket ...

Fresh off receiving a PMA, TherOx is now in the process of being acquired by Zoll Medical, an Asahi Kasei Group Company. Additional terms of the deal were not disclosed. Irvine, CA-based TherOX is ...